- Report
- September 2026
- 174 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 370 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- May 2026
- 180 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- January 2026
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- January 2026
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- June 2026
- 330 Pages
Global
From €4498EUR$4,950USD£3,866GBP
- Report
- November 2025
- 270 Pages
Global
From €4498EUR$4,950USD£3,866GBP
- Report
- November 2025
- 307 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- March 2026
- 120 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- February 2026
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- January 2026
- 180 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- March 2026
- 135 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2026
- 140 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 138 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 136 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 149 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- September 2026
- 495 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 262 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP

The Blood Component market is a subset of the biopharmaceutical industry that focuses on the production and distribution of blood components, such as red blood cells, platelets, and plasma. These components are used to treat a variety of medical conditions, including anemia, cancer, and trauma. The market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products.
The Blood Component market is a highly competitive space, with a number of companies vying for market share. Some of the major players in the market include Grifols, CSL Behring, Octapharma, Kedrion, and Biotest. Show Less Read more